1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 281 F.Supp.2d
  5. 281 F.Supp.2d 751 (2003)
 

IN RE WELLBUTRIN SR/ZYBAN ANTITRUST LITIGATION

No. 02-CV-4398.

281 F.Supp.2d 751 (2003)

In re WELLBUTRIN SR/ZYBAN ANTITRUST LITIGATION

United States District Court, E.D. Pennsylvania.

July 24, 2003.

Attorney(s) appearing for the Case

Anthony J. Bolognese, Bolognese & Associates, LLC, Philadelphia, PA, Krishna B. Narine, Schiffrin & Barroway, LLP, Bala Cynwyd, PA, Michael J. Flannery, The David Danis Law Firm PC, St. Louis, MO, for Plaintiff MC-UA Local 119 Health And Welfare Plan.

Amy R. Mudge, H. Holden Brooks, Arnold & Porter, Washington, DC, Leslie E. John, Mark S. Stewart, Ballard, Spahr, Andrews & Ingersoll, LLP, Philadelphia, PA, Timothy A. Thelen, Research Triangle Park, NC, for Defendants Glaxosmithkline, PLC and Smithkline Beecham Corporation.

MEMORANDUM AND ORDER

KAUFFMAN, District Judge.

Plaintiffs bring this putative class action on behalf of all indirect purchasers of Wellbutrin SR and Zyban ("Wellbutrin SR")1 alleging that Defendants GlaxoSmithKline plc and Smithkline Beecham Corporation ("Defendants") engaged in a series of anticompetitive and unlawful actions that extended their exclusivity of the sale of Wellbutrin SR. Plaintiffs assert that they are...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases